Research map: Artificial intelligence in peptide cancer vaccine design: from neoantigen discovery to immunogenicity prediction

Back to the article

Papers in this map

  1. dbSNP: the NCBI database of genetic variation · Stephen T. Sherry · 2001 · 7958 citations · Cited by this paper
  2. Rethinking polyphenol oxidases in wheat: beyond the “low-PPO is always better” paradigm · 2026 · Related
  3. Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion · Robert D. Schreiber · 2011 · 6575 citations · Cited by this paper
  4. From toxicogenomics to predictive toxicology and exposomics: defining the next decade of gene–environment research · 2026 · Related
  5. VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing · Daniel C. Koboldt · 2012 · 5420 citations · Cited by this paper
  6. Machine learning prioritization identifies PANX1 as an inflammation-associated candidate regulator in lung adenocarcinoma · 2026 · Related
  7. COSMIC: the Catalogue Of Somatic Mutations In Cancer · John G. Tate · 2018 · 5382 citations · Cited by this paper
  8. Assessment of paralogue annotation for improving diagnostic accuracy in CALM1, CALM2, and CALM3 genes · 2026 · Related
  9. Neoantigens in cancer immunotherapy · Ton N. Schumacher · 2015 · 4897 citations · Cited by this paper
  10. Suspected parental gonadal/gonadosomatic mosaicism for a TINF2 mutation in two sisters with dyskeratosis congenita · 2026 · Related
  11. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade · Nicholas McGranahan · 2016 · 3184 citations · Cited by this paper
  12. Case Report: First report of spinal stenosis in Imagawa-Matsumoto syndrome: a novel SUZ12 variant in an 11-year-old Chinese child · 2026 · Related
  13. An immunogenic personal neoantigen vaccine for patients with melanoma · Patrick Alexander Ott · 2017 · 3025 citations · Cited by this paper
  14. Clinical application value of preconception and prenatal carrier screening in Yinchuan · 2026 · Related
  15. DELLY: structural variant discovery by integrated paired-end and split-read analysis · Tobias Rausch · 2012 · 2813 citations · Cited by this paper
  16. A reproducible pretreatment mucosal-inflammatory-remodeling state is associated with induction-phase anti-tumor necrosis factor non-response in ulcerative colitis · 2026 · Related
  17. Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications · Xiaoyu Chen · 2015 · 2511 citations · Cited by this paper
  18. Cancer vaccines: advances, hurdles, and future directions · 2025 · Related
  19. NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data · Birkir Reynisson · 2020 · 2489 citations · Cited by this paper
  20. A universal SNP and small-indel variant caller using deep neural networks · Ryan E. Poplin · 2018 · 2005 citations · Cited by this paper
  21. Strelka2: fast and accurate calling of germline and somatic variants · Sangtae Kim · 2018 · 1826 citations · Cited by this paper
  22. Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer · Luis Alfonso Rojas · 2023 · 1407 citations · Cited by this paper
  23. CD8+ T cell differentiation and dysfunction in cancer · Mary Philip · 2021 · 1102 citations · Cited by this paper
  24. Neoantigens: promising targets for cancer therapy · Na Xie · 2023 · 1004 citations · Cited by this paper
  25. Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study · Jeffrey S. Weber · 2024 · 873 citations · Cited by this paper
  26. Multimodal deep learning for biomedical data fusion: a review · Sören Richard Stahlschmidt · 2021 · 747 citations · Cited by this paper
  27. Peptide-Based Vaccines: Current Progress and Future Challenges · Ryan J. Malonis · 2019 · 618 citations · Cited by this paper
  28. AIRE expands: new roles in immune tolerance and beyond · Mark Stuart Anderson · 2016 · 269 citations · Cited by this paper
  29. Peptide‐ MHC class I stability is a better predictor than peptide affinity of CTL immunogenicity · Mikkel Nors Harndahl · 2012 · 231 citations · Cited by this paper
  30. Development of Peptide-Based Vaccines for Cancer · Noraini Abd-Aziz · 2022 · 158 citations · Cited by this paper
  31. The global challenge of cancer · 2020 · 133 citations · Cited by this paper
  32. Dendritic Cell Vaccines: A Shift from Conventional Approach to New Generations · Kyu-Won Lee · 2023 · 119 citations · Cited by this paper
  33. Personalized neoantigen vaccination with synthetic long peptides: recent advances and future perspectives · Xiaotong Chen · 2020 · 110 citations · Cited by this paper
  34. Spotlight on TAP and its vital role in antigen presentation and cross-presentation · Ian Mantel · 2021 · 98 citations · Cited by this paper
  35. Targeting Peptides: The New Generation of Targeted Drug Delivery Systems · Biagio Todaro · 2023 · 96 citations · Cited by this paper
  36. Antigen discovery and specification of immunodominance hierarchies for MHCII-restricted epitopes · Daniel B. Graham · 2018 · 83 citations · Cited by this paper
  37. Artificial intelligence applied in neoantigen identification facilitates personalized cancer immunotherapy · Yu Cai · 2023 · 80 citations · Cited by this paper
  38. The role of neoantigens and tumor mutational burden in cancer immunotherapy: advances, mechanisms, and perspectives · Shengbo Sun · 2025 · 77 citations · Cited by this paper
  39. The Cancer Epitope Database and Analysis Resource (CEDAR) · Zeynep Koşaloğlu‐Yalçın · 2022 · 74 citations · Cited by this paper

Source: OpenAlex (CC0)